| Product Code: ETC10067478 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Vietnam Antimicrobial Resistance Market Overview |
3.1 Vietnam Country Macro Economic Indicators |
3.2 Vietnam Antimicrobial Resistance Market Revenues & Volume, 2021 & 2031F |
3.3 Vietnam Antimicrobial Resistance Market - Industry Life Cycle |
3.4 Vietnam Antimicrobial Resistance Market - Porter's Five Forces |
3.5 Vietnam Antimicrobial Resistance Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.6 Vietnam Antimicrobial Resistance Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 Vietnam Antimicrobial Resistance Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.8 Vietnam Antimicrobial Resistance Market Revenues & Volume Share, By Pathogen, 2021 & 2031F |
4 Vietnam Antimicrobial Resistance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of infectious diseases in Vietnam |
4.2.2 Growth in healthcare infrastructure and expenditure |
4.2.3 Rising awareness about the importance of infection control and antimicrobial stewardship |
4.3 Market Restraints |
4.3.1 Limited access to appropriate antibiotics in rural areas |
4.3.2 Lack of stringent regulations and enforcement on antimicrobial usage |
4.3.3 High levels of self-medication leading to misuse of antibiotics |
5 Vietnam Antimicrobial Resistance Market Trends |
6 Vietnam Antimicrobial Resistance Market, By Types |
6.1 Vietnam Antimicrobial Resistance Market, By Indication |
6.1.1 Overview and Analysis |
6.1.2 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Indication, 2021- 2031F |
6.1.3 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Complicated Urinary Tract Infections (cUTI), 2021- 2031F |
6.1.4 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Blood stream infections, 2021- 2031F |
6.1.5 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Acute bacterial skin and skin structure infections (ABSSSI), 2021- 2031F |
6.1.6 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Hospital acquired bacterial pneumonia and ventilator acquired bacterial pneumonia (HABP and VABP), 2021- 2031F |
6.1.7 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Community acquired pneumonia (CAP), 2021- 2031F |
6.1.8 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.2 Vietnam Antimicrobial Resistance Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Combination therapies, 2021- 2031F |
6.2.3 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Tetracyclines, 2021- 2031F |
6.2.4 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Cephalosporins, 2021- 2031F |
6.2.5 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Glycopeptides and Lipoglycopeptides, 2021- 2031F |
6.2.6 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Oxazolidinones, 2021- 2031F |
6.2.7 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Vietnam Antimicrobial Resistance Market, By Mechanism of Action |
6.3.1 Overview and Analysis |
6.3.2 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Protein Synthesis Inhibitors, 2021- 2031F |
6.3.3 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Cell Wall Synthesis Inhibitors, 2021- 2031F |
6.3.4 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Vietnam Antimicrobial Resistance Market, By Pathogen |
6.4.1 Overview and Analysis |
6.4.2 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Klebsiella pneumoniae, 2021- 2031F |
6.4.3 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Pseudomonas aeruginosa, 2021- 2031F |
6.4.4 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Staphylococcus aureus, 2021- 2031F |
6.4.5 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Enterococcus Spp, 2021- 2031F |
6.4.6 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Escherichia coli, 2021- 2031F |
6.4.7 Vietnam Antimicrobial Resistance Market Revenues & Volume, By Others, 2021- 2031F |
7 Vietnam Antimicrobial Resistance Market Import-Export Trade Statistics |
7.1 Vietnam Antimicrobial Resistance Market Export to Major Countries |
7.2 Vietnam Antimicrobial Resistance Market Imports from Major Countries |
8 Vietnam Antimicrobial Resistance Market Key Performance Indicators |
8.1 Rate of antibiotic prescriptions by healthcare providers |
8.2 Percentage of hospitals implementing antimicrobial stewardship programs |
8.3 Number of reported cases of antibiotic-resistant infections in healthcare settings |
9 Vietnam Antimicrobial Resistance Market - Opportunity Assessment |
9.1 Vietnam Antimicrobial Resistance Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.2 Vietnam Antimicrobial Resistance Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 Vietnam Antimicrobial Resistance Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.4 Vietnam Antimicrobial Resistance Market Opportunity Assessment, By Pathogen, 2021 & 2031F |
10 Vietnam Antimicrobial Resistance Market - Competitive Landscape |
10.1 Vietnam Antimicrobial Resistance Market Revenue Share, By Companies, 2024 |
10.2 Vietnam Antimicrobial Resistance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here